Physician profile
Stephen Mills
NPI 1326153867
$2,719.28
in general payments reported to CMS, 2019-2025
30 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $505 · 2021: $573 · 2022: $361 · 2023: $315 · 2024: $86.09 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.80 | 2020-2023 | |
| Boston Scientific Corporation | $360.89 | 2019 | |
| Smith+Nephew, INC. | $269.46 | 2019-2025 | Collagenase Santyl, Pico 7 |
| Amgen INC. | $244.24 | 2019-2024 | Prolia, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $221.49 | 2019-2022 | |
| Pfizer INC. | $185.03 | 2019-2023 | |
| Astellas Pharma US INC | $110.10 | 2021-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $85.89 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Organogenesis INC. | $59.69 | 2021 | |
| Kerecis Limited | $55.17 | 2019 | |
| Reprise Biomedical, INC. | $47.87 | 2022-2025 | Miro3d |
| Shield Therapeutics INC | $46.68 | 2022-2023 | Accrufer |
| Radius Health, INC. | $45.13 | 2020-2023 | Tymlos |
| Medtronic, INC. | $41.71 | 2023 | Sonicision |
| Organon LLC | $33.01 | 2021-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $33.00 | 2019 | |
| Convatec INC. | $31.26 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.87 | 2019 | |
| Therapeuticsmd, INC. | $26.29 | 2019-2020 | |
| Exeltis, USA INC. | $24.71 | 2025 | Slynd |
| Misonix INC | $24.65 | 2020-2021 | |
| Angiodynamics, INC. | $21.58 | 2025 | Auryon Laser System 100-120 Vac |
| Scynexis, INC. | $17.26 | 2022 | |
| Bioventus LLC | $14.52 | 2022 | |
| Sumitomo Pharma America, INC. | $13.78 | 2023 | Myfembree |
| Kci USA, INC. | $13.36 | 2021 | |
| Minerva Surgical, INC | $13.32 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.90 | 2019 | |
| Daiichi Sankyo INC. | $12.54 | 2021 | |
| Integra Lifesciences Corporation | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.